XRAY vs HSIC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

XRAY

42.7
AI Score
VS
HSIC Wins

HSIC

58.8
AI Score

Investment Advisor Scores

XRAY

43score
Recommendation
HOLD

HSIC

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY HSIC Winner
Forward P/E 7.2359 14.9477 XRAY
PEG Ratio 0.7238 1.7595 XRAY
Revenue Growth -4.1% 4.0% HSIC
Earnings Growth 15.2% 26.2% HSIC
Tradestie Score 42.7/100 58.8/100 HSIC
Profit Margin -15.0% 3.1% HSIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: +14.8% · 3M: -15.7% HSIC 1M: +4.0% · 3M: -1.9%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.0 · Price: $9.76

HSIC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.1 · Price: $88.42

Fundamentals Snapshot

Metric XRAY HSIC
Market Cap — —
Forward P/E 7.8 14.7
Trailing P/E — 24.3
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.5% 0.3%
Operating Margin 0.0% 0.1%
EPS -0.61 3.65
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, HSIC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.